Editorial: Innovative approaches to catalyze preclinical and clinical research on amyotrophic lateral sclerosis (ALS) and related disorders
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-03-01
|
| Series: | Frontiers in Neuroscience |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fnins.2025.1582539/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850038136162222080 |
|---|---|
| author | Thibaut Burg Thibaut Burg Laura Tzeplaeff Raphaelle Cassel Paul Lingor Paul Lingor Paul Lingor |
| author_facet | Thibaut Burg Thibaut Burg Laura Tzeplaeff Raphaelle Cassel Paul Lingor Paul Lingor Paul Lingor |
| author_sort | Thibaut Burg |
| collection | DOAJ |
| format | Article |
| id | doaj-art-9351465d255346dd9e1e946ba4e1e2b9 |
| institution | DOAJ |
| issn | 1662-453X |
| language | English |
| publishDate | 2025-03-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Neuroscience |
| spelling | doaj-art-9351465d255346dd9e1e946ba4e1e2b92025-08-20T02:56:39ZengFrontiers Media S.A.Frontiers in Neuroscience1662-453X2025-03-011910.3389/fnins.2025.15825391582539Editorial: Innovative approaches to catalyze preclinical and clinical research on amyotrophic lateral sclerosis (ALS) and related disordersThibaut Burg0Thibaut Burg1Laura Tzeplaeff2Raphaelle Cassel3Paul Lingor4Paul Lingor5Paul Lingor6Department of Neurosciences, Experimental Neurology and Leuven Brain Institute (LBI), KU Leuven-University of Leuven, Leuven, BelgiumLaboratory of Neurobiology, Center for Brain & Disease Research, VIB, Leuven, BelgiumClinical Department of Neurology, School of Medicine, rechts der Isar Hospital, Technical University of Munich, Munich, GermanyUMR-S 1329, Strasbourg Translational Neuroscience & Psychiatry STEP-CRBS, University of Strasbourg, INSERM, Strasbourg, FranceClinical Department of Neurology, School of Medicine, rechts der Isar Hospital, Technical University of Munich, Munich, GermanyGerman Center for Neurodegenerative Diseases (DZNE), Munich, GermanyMunich Cluster for Systems Neurology (SyNergy), Munich, Germanyhttps://www.frontiersin.org/articles/10.3389/fnins.2025.1582539/fullAmyotrophic lateral sclerosis (ALS)motor neuronneurodegenerationclinical researchbiomarkertherapy |
| spellingShingle | Thibaut Burg Thibaut Burg Laura Tzeplaeff Raphaelle Cassel Paul Lingor Paul Lingor Paul Lingor Editorial: Innovative approaches to catalyze preclinical and clinical research on amyotrophic lateral sclerosis (ALS) and related disorders Frontiers in Neuroscience Amyotrophic lateral sclerosis (ALS) motor neuron neurodegeneration clinical research biomarker therapy |
| title | Editorial: Innovative approaches to catalyze preclinical and clinical research on amyotrophic lateral sclerosis (ALS) and related disorders |
| title_full | Editorial: Innovative approaches to catalyze preclinical and clinical research on amyotrophic lateral sclerosis (ALS) and related disorders |
| title_fullStr | Editorial: Innovative approaches to catalyze preclinical and clinical research on amyotrophic lateral sclerosis (ALS) and related disorders |
| title_full_unstemmed | Editorial: Innovative approaches to catalyze preclinical and clinical research on amyotrophic lateral sclerosis (ALS) and related disorders |
| title_short | Editorial: Innovative approaches to catalyze preclinical and clinical research on amyotrophic lateral sclerosis (ALS) and related disorders |
| title_sort | editorial innovative approaches to catalyze preclinical and clinical research on amyotrophic lateral sclerosis als and related disorders |
| topic | Amyotrophic lateral sclerosis (ALS) motor neuron neurodegeneration clinical research biomarker therapy |
| url | https://www.frontiersin.org/articles/10.3389/fnins.2025.1582539/full |
| work_keys_str_mv | AT thibautburg editorialinnovativeapproachestocatalyzepreclinicalandclinicalresearchonamyotrophiclateralsclerosisalsandrelateddisorders AT thibautburg editorialinnovativeapproachestocatalyzepreclinicalandclinicalresearchonamyotrophiclateralsclerosisalsandrelateddisorders AT lauratzeplaeff editorialinnovativeapproachestocatalyzepreclinicalandclinicalresearchonamyotrophiclateralsclerosisalsandrelateddisorders AT raphaellecassel editorialinnovativeapproachestocatalyzepreclinicalandclinicalresearchonamyotrophiclateralsclerosisalsandrelateddisorders AT paullingor editorialinnovativeapproachestocatalyzepreclinicalandclinicalresearchonamyotrophiclateralsclerosisalsandrelateddisorders AT paullingor editorialinnovativeapproachestocatalyzepreclinicalandclinicalresearchonamyotrophiclateralsclerosisalsandrelateddisorders AT paullingor editorialinnovativeapproachestocatalyzepreclinicalandclinicalresearchonamyotrophiclateralsclerosisalsandrelateddisorders |